SIGNPATH PHARMA, INC. Patent Applications Pending
37 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2026-02-06: Application PCTUS2026014270; Invention LIPOSOMAL CURCUMIN AND STANDARD RADIATION AND TEMOZOLOMIDE FOR TREATMENT OF HIGH-GRADE GLIOMAS; Applicant SIGNPATH PHARMA INC.; Status PCT - International Search Report Mailed to IB.
- 2026-01-15: Application 19450053; Invention Dosing Regimens for Treatment of Glioblastoma; Applicant Signpath Pharma Inc.; Status Docketed New Case - Ready for Examination.
- 2025-02-11: Application 63757205; Invention Liposomal Curcumin and Standard Radiation and Temozolomide for Treatment of High-Grade Gliomas; Applicant SignPath Pharma Inc.; Status Provisional Application Expired.
- 2024-08-07: Application PCTUS2024041253; Invention CARDIOPROTECTIVE LIPIDS AND METHODS OF USE; Applicant SIGNPATH PHARMA INC.; Status PCT - International Search Report Mailed to IB.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | PCTUS2026014270 | LIPOSOMAL CURCUMIN AND STANDARD RADIATION AND TEMOZOLOMIDE FOR TREATMENT OF HIGH-GRADE GLIOMAS | SIGNPATH PHARMA INC. | PCT - International Search Report Mailed to IB | PETER P. SORDILLO MATTHIAS HOLDHOFF | United States United States | MATOS NEGRON, TAINA DEL MAR | |
| 2026-01-15 | 19450053 | Dosing Regimens for Treatment of Glioblastoma | Signpath Pharma Inc. | Docketed New Case - Ready for Examination | US20260144750A1 | Peter Sordillo | United States | CENTRAL, DOCKET |
| 2025-02-11 | 63757205 | Liposomal Curcumin and Standard Radiation and Temozolomide for Treatment of High-Grade Gliomas | SignPath Pharma Inc. | Provisional Application Expired | Peter P. Sordillo Matthias Holdhoff | United States United States | ||
| 2024-08-07 | PCTUS2024041253 | CARDIOPROTECTIVE LIPIDS AND METHODS OF USE | SIGNPATH PHARMA INC. | PCT - International Search Report Mailed to IB | DANIEL EMIL LEVY | United States | THOMAS, SHANE M | |
| 2023-09-08 | PCTUS2023073755 | CARDIOPROTECTIVE LIPID AND METHOD OF USE | SIGNPATH PHARMA, INC. | PCT - International Search Report Mailed to IB | JAMES MCCHESNEY ANNIE BOUCHARD SARAVANAN KAPPUSAMY JOHN KALLIKAT AUGUSTINE DANIEL EMIL LEVY DANY SALVAIL | United States Canada India India United States Canada | MATOS NEGRON, TAINA DEL MAR | |
| 2023-08-28 | 18457037 | CARDIOPROTECTIVE LIPIDS AND METHODS OF USE | Signpath Pharma, Inc. | Final Rejection Mailed | US20240025928A1 | Daniel Emil Levy | United States | O DELL, DAVID K |
| 2023-06-29 | 18260012 | LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES | Signpath Pharma, Inc. | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20240091242A1 | Peter P. Sordillo Dan Salvail Sebastien M. Labbe | United States Canada Canada | RODRIGUEZ, RAYNA B |
| 2022-03-02 | PCTUS2022018504 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | SIGNPATH PHARMA, INC. | PCT - International Search Report Mailed to IB | ASHLEIGH HOCKING SONYA KLEBE ALEXANDRA L. FARRALL PETER P. SORDILLO | Australia Australia Australia United States | KIM, HARRY CHONG HYUN | |
| 2022-01-21 | PCTUS2022013283 | LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES | SIGNPATH PHARMA, INC | PCT - International Search Report Mailed to IB | PATER P. SORDILLO ANDREA ALLAIRE SEBASTIEN M. LABBE DAN SALVAIL ANNIE BOUCHARD | United States Canada Canada Canada Canada | KIM, HARRY CHONG HYUN | |
| 2021-07-13 | PCTUS2021041403 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | SIGNPATH PHARMA, INC. | PCT - International Search Report Mailed to IB | LAWRENCE HELSON PETER P. SORDILLO | United States United States | KIM, HARRY CHONG HYUN | |
| 2021-03-03 | 63156090 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | Signpath Pharma, Inc. | Provisional Application Expired | Ashleigh Hocking Peter P. Sordillo Alexandra L. Farrall Sonja Klebe | Australia United States Australia Australia | ||
| 2021-01-29 | 63143511 | LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES | Signpath Pharma, Inc. | Provisional Application Expired | Peter P. Sordillo Andrea Allaire Annie Bouchard Dan Salvail Sebastien M. Labbe | United States Canada Canada Canada Canada | ||
| 2019-06-06 | 16433555 | Liposomal Mitigation of Drug-Induced Long QT Syndrome and Potassium Delayed-Rectifier Current | Signpath Pharma, Inc. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20190321293A1 | Lawrence Helson | United States | RONEY, CELESTE A |
| 2019-03-28 | PCTUS2019024495 | DOSING REGIMENS FOR TREATMENT OF PROLIFERATIVE DISORDERS | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | PETER SORDILLO | United States | ||
| 2018-10-19 | PCTUS2018056721 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ANNIE BOUCHARD GEORGE M. SHOPP MUHAMMED MAJEED LAWRENCE HELSON | Canada United States United States United States | ||
| 2018-07-06 | PCTUS2018040988 | COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ANNIE BOUCHARD | Canada | ||
| 2018-06-26 | 62690196 | Novel Lipids | Signpath Pharma, Inc. | Provisional Application Expired | James McChesney Annie Bouchard Saravanan Kappusamy John Kallikat Augustine | United States Canada India India | ||
| 2018-04-09 | 62655095 | Dosing Regimens for Treatment of Proliferative Disorders | SignPath Pharma Inc. | Provisional Application Expired | Peter Sordillo | United States | ||
| 2017-11-09 | PCTUS2017060936 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON | United States | ||
| 2017-10-19 | PCTUS2017057446 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON ANNIE BOUCHARD MUHAMMED MAJEED GEORGE M. SHOPP | United States Canada United States United States | ||
| 2017-07-07 | 62529980 | COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY | SignPath Pharma Inc. | Provisional Application Expired | Annie Bouchard | Canada | ||
| 2017-04-24 | PCTUS2017029114 | PREVENTION OF DRUG-INDUCED ATRIO-VENTRICULAR BLOCK | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ANNIE BOUCHARD LAWRENCE HELSON | Canada United States | ||
| 2017-02-22 | PCTUS2017018889 | SPHINGOSINE KINASE INHIBITORS AND CERAMIDE FOR MAINTENANCE THERAPY OF GLIOBLASTOMA | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON PETER SORDILLO LAURA A. SORDILLO | United States United States | ||
| 2016-04-27 | 62328307 | PREVENTION OF DRUG-INDUCED ATRIO-VENTRICULAR BLOCK | SignPath Pharma Inc. | Provisional Application Expired | Lawrence Helson Annie Bouchard | United States Canada | ||
| 2016-03-02 | 62302542 | SPHINGOSINE KINASE INHIBITORS AND CERAMIDE FOR MAINTENANCE THERAPY OF GLIOBLASTOMA | SignPath Pharma Inc. | Provisional Application Expired | Lawrence Helson Laura A. Sordillo Peter Sordillo | United States United States United States | ||
| 2015-09-18 | 62220635 | TREATMENT FOR GLIOBLASTOMA | SignPath Pharma Inc. | Provisional Application Expired | Laura A. Sordillo Peter P. Sordillo Lawrence Helson | United States United States United States | ||
| 2015-04-01 | 62141583 | CURCUMIN FOR TREATING INTERVERTEBRAL DISC DISEASE | SignPath Pharma Inc. | Provisional Application Expired | Diana C. Sordillo Peter P. Sordillo Lawrence Helson | United States United States United States | ||
| 2014-12-31 | 62098898 | CURCUMIN SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | SignPath Pharma Inc. | Provisional Application Expired | Peter P. Sordillo Lawrence Helson | United States United States | ||
| 2014-12-18 | PCTUS2014071246 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ANNIE BOUCHARD LAWRENCE HELSON GEORGE M. SHOPP | Canada United States United States | ||
| 2014-11-21 | PCTUS2014066944 | INTRAVENOUS SYNTHETIC CURCUMIN (S-CURCUMIN) FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON | United States | ||
| 2014-06-03 | 62007244 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SignPath Pharma Inc. | Provisional Application Expired | Lawrence Helson George M. Shopp Annie Bouchard Muhammed Majeed | United States United States Canada United States | ||
| 2014-04-09 | 61977417 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SignPath Pharma Inc. | Provisional Application Expired | Lawrence Helson George M. Shopp Annie Bouchard | United States United States Canada | ||
| 2013-12-18 | 61917426 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SignPath Pharma Inc. | Provisional Application Expired | Lawrence Helson George M. Shopp Annie Bouchard | United States United States Canada | ||
| 2013-08-31 | PCTUS2013057744 | CURCUMIN-ER, A LIPOSOMAL-PLGA SUSTAINED RELEASE NANOCURCUMIN FOR MINIMIZING QT PROLONGATION FOR CANCER THERAPY | SIGNPATH PHARMA, INC. UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER | RO PROCESSING COMPLETED-PLACED IN STORAGE | JAMBOOR K. VISHWANATHA ANANDITA MUKERJEE AMALENDU PRAKASH RANJAN LAWRENCE HELSON | United States United States United States United States | ||
| 2012-06-03 | PCTUS2012040637 | LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT | SIGNPATH PHARMA INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON | United States | ||
| 2012-03-15 | PCTUS2012029230 | CURCUMIN COMBINATION WITH ANTI-TYPE 2 DIABETIC DRUGS FOR PREVENTION AND TREATMENT OF DISEASE SEQUELAE, DRUG-RELATED ADVERSE REACTIONS, AND IMPROVED GLYCEMIC CONTROL | SIGNPATH PHARMA, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | LAWRENCE HELSON | United States | ||
| 2011-03-22 | PCTUS2011029393 | INTRAVENOUS CURCUMIN AND DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE AND STRESS DISORDERS | SIGNPATH PHARMA INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | SIMON CHIU LAWRENCE HELSON | United States United States |